Tesamorelin, sermorelin, and GHRH analogs: comparative endocrine review
Reviews in Endocrine and Metabolic Disorders
2024
Study summary
Comparative review of GHRH analogs and GH-axis therapeutics including tesamorelin and sermorelin.
Peptides studied
Stack studied
GH Optimization Stack
Key findings
Tesamorelin had the strongest modern clinical data, especially for visceral adiposity outcomes.
Study details
Study type
review article
Journal
Reviews in Endocrine and Metabolic Disorders
DOI / PubMed
10.1007/s11154-023-09780-9
Year
2024
Explore peptide profiles
Discover compounds, understand their mechanisms, and explore the research behind each peptide.
